Annual Current Assets
$196.25 M
+$64.86 M+49.36%
31 December 2023
Summary:
Inozyme Pharma annual total current assets is currently $196.25 million, with the most recent change of +$64.86 million (+49.36%) on 31 December 2023. During the last 3 years, it has risen by +$45.27 million (+29.98%). INZY annual current assets is now at all-time high.INZY Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$140.94 M
-$12.03 M-7.86%
30 September 2024
Summary:
Inozyme Pharma quarterly total current assets is currently $140.94 million, with the most recent change of -$12.03 million (-7.86%) on 30 September 2024. Over the past year, it has dropped by -$59.92 million (-29.83%). INZY quarterly current assets is now -29.83% below its all-time high of $200.86 million, reached on 30 September 2023.INZY Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.4% | -29.8% |
| 3 y3 years | +30.0% | +7.9% |
| 5 y5 years | +353.6% | - |
INZY Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +70.2% | -29.8% | +40.1% |
| 5 y | 5 years | at high | +353.6% | -29.8% | +197.0% |
| alltime | all time | at high | +353.6% | -29.8% | +197.0% |
Inozyme Pharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $140.94 M(-7.9%) |
| June 2024 | - | $152.96 M(-12.3%) |
| Mar 2024 | - | $174.32 M(-11.2%) |
| Dec 2023 | $4.60 M(-41.1%) | $196.25 M(-2.3%) |
| Sept 2023 | - | $200.86 M(+39.9%) |
| June 2023 | - | $143.59 M(+7.0%) |
| Mar 2023 | - | $134.15 M(+2.1%) |
| Dec 2022 | $7.80 M | $131.39 M(-10.0%) |
| Sept 2022 | - | $145.93 M(-5.1%) |
| June 2022 | - | $153.75 M(+52.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $100.58 M(-12.8%) |
| Dec 2021 | $8.20 M(-55.4%) | $115.34 M(-11.7%) |
| Sept 2021 | - | $130.58 M(-7.4%) |
| June 2021 | - | $140.96 M(-4.8%) |
| Mar 2021 | - | $148.04 M(-1.9%) |
| Dec 2020 | $18.38 M(+3698.3%) | $150.98 M(-7.9%) |
| Sept 2020 | - | $163.98 M(+153.6%) |
| June 2020 | - | $64.66 M(-13.7%) |
| Mar 2020 | - | $74.96 M(+57.9%) |
| Dec 2019 | $484.00 K(+75.4%) | $47.46 M |
| Dec 2018 | $276.00 K | - |
FAQ
- What is Inozyme Pharma annual total current assets?
- What is the all time high annual current assets for Inozyme Pharma?
- What is Inozyme Pharma annual current assets year-on-year change?
- What is Inozyme Pharma quarterly total current assets?
- What is the all time high quarterly current assets for Inozyme Pharma?
- What is Inozyme Pharma quarterly current assets year-on-year change?
What is Inozyme Pharma annual total current assets?
The current annual current assets of INZY is $196.25 M
What is the all time high annual current assets for Inozyme Pharma?
Inozyme Pharma all-time high annual total current assets is $196.25 M
What is Inozyme Pharma annual current assets year-on-year change?
Over the past year, INZY annual total current assets has changed by +$64.86 M (+49.36%)
What is Inozyme Pharma quarterly total current assets?
The current quarterly current assets of INZY is $140.94 M
What is the all time high quarterly current assets for Inozyme Pharma?
Inozyme Pharma all-time high quarterly total current assets is $200.86 M
What is Inozyme Pharma quarterly current assets year-on-year change?
Over the past year, INZY quarterly total current assets has changed by -$59.92 M (-29.83%)